ZTS
36
-7
ITW
48
-7
K
45
-5
SO
39
-9
ES
7
-7
MPC
23
-5
HSIC
39
-11
PFE
32
-5
HAS
26
-6
MKC
54
-5
AKAM
48
-5
ZBH
53
-7
MMC
41
-10
UPS
45
-5
CA
13
-12
RL
65
-7
SLB
39
-6
NTRS
24
-11
BWA
41
-5
PBI
48
-10
ZTS
36
-7
ITW
48
-7
K
45
-5
SO
39
-9
ES
7
-7
MPC
23
-5
HSIC
39
-11
PFE
32
-5
HAS
26
-6
MKC
54
-5
AKAM
48
-5
ZBH
53
-7
MMC
41
-10
UPS
45
-5
CA
13
-12
RL
65
-7
SLB
39
-6
NTRS
24
-11
BWA
41
-5
PBI
48
-10
Financhill
Back

Viking Therapeutics 10K Form

Sell
28

VKTX
Viking Therapeutics

Last Price:
40.77
Seasonality Move:
40.87%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive VKTX News And Ratings

See the #1 stock for the next 7 days that we like better than VKTX

VKTX Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-21.96M
Price / Cash Flow: 0
Annual Sales: $8.18
Price / Book: 5.71

Profitability

EPS (TTM): -0.93000
Net Income (TTM): $-99.15M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Viking Therapeutics Earnings Forecast

Key Viking Therapeutics Financial Ratios

  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 11 years have been positive in 5 years.

Viking Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: VKTX
CUSIP: 92686J
Website: vikingtherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

VKTX Technical Analysis vs Fundamental Analysis

Sell
28
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy or a Sell?